- Home
- OFG vs IDYA Comparison
OFG vs IDYA Comparison
Compare OFG & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- IDYA
- Stock Information
- Founded
- OFG 1964
- IDYA 2015
- Country
- OFG United States
- IDYA United States
- Employees
- OFG N/A
- IDYA N/A
- Industry
- OFG Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- OFG Finance
- IDYA Health Care
- Exchange
- OFG Nasdaq
- IDYA Nasdaq
- Market Cap
- OFG 1.8B
- IDYA 1.5B
- IPO Year
- OFG N/A
- IDYA 2019
- Fundamental
- Price
- OFG $41.33
- IDYA $17.82
- Analyst Decision
- OFG Buy
- IDYA Strong Buy
- Analyst Count
- OFG 3
- IDYA 13
- Target Price
- OFG $44.00
- IDYA $53.58
- AVG Volume (30 Days)
- OFG 352.7K
- IDYA 1.5M
- Earning Date
- OFG 04-23-2025
- IDYA 05-06-2025
- Dividend Yield
- OFG 2.88%
- IDYA N/A
- EPS Growth
- OFG 6.67
- IDYA N/A
- EPS
- OFG 4.18
- IDYA N/A
- Revenue
- OFG $623,009,000.00
- IDYA $7,000,000.00
- Revenue This Year
- OFG $0.52
- IDYA $121.20
- Revenue Next Year
- OFG $3.97
- IDYA $302.20
- P/E Ratio
- OFG $9.76
- IDYA N/A
- Revenue Growth
- OFG N/A
- IDYA N/A
- 52 Week Low
- OFG $33.15
- IDYA $13.45
- 52 Week High
- OFG $47.66
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- OFG 66.33
- IDYA 50.25
- Support Level
- OFG $40.32
- IDYA $16.82
- Resistance Level
- OFG $42.24
- IDYA $21.43
- Average True Range (ATR)
- OFG 1.04
- IDYA 1.11
- MACD
- OFG 0.51
- IDYA -0.09
- Stochastic Oscillator
- OFG 91.41
- IDYA 36.66
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.